STRIvE-02: A First-in-Human Phase I Study of Systemically Administered B7-H3 Chimeric Antigen Receptor T Cells for Patients With Relapsed/Refractory Solid Tumors.

Details

Language :

English

ISSN :

0732183X

Volume :

42

Issue :

35

Database :

Supplemental Index

Journal :

Journal of Clinical Oncology

Publication Type :

Academic Journal

Accession number :

181466225

Full Text :

https://doi.org/10.1200/JCO.23.02229